Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-CIN: NSAIDs and Steroids in Cataract Surgery
NCT05331690Phase 4Unknown
- Sponsor
- Oslo University Hospital
- Start
- Nov 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of nepafenac, dexamethasone iontophoretic patch in post-operative ocular inflammation, cystoid macular edema (CME), sponsored by Oslo University Hospital. Status: unknown.
02
Drugs
nepafenacdexamethasone iontophoretic patch
03
Conditions
post-operative ocular inflammationcystoid macular edema (CME)
Beyond the preview
Go deeper on NCT05331690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05331690.